BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 26873486)

  • 1. Bone marrow stromal cells induced activation of nuclear factor κB signaling protects non-Hodgkin's B lymphoma cells from apoptosis.
    Su T; Li J; Meng M; Zhao S; Xu Y; Ding X; Jiang H; Ma X; Qian J; Han W; Sun L; Li X; Liu Z; Pan L; Xue X
    Tumour Biol; 2016 Aug; 37(8):10745-52. PubMed ID: 26873486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphoma cell adhesion-induced expression of B cell-activating factor of the TNF family in bone marrow stromal cells protects non-Hodgkin's B lymphoma cells from apoptosis.
    Lwin T; Crespo LA; Wu A; Dessureault S; Shu HB; Moscinski LC; Sotomayor E; Dalton WS; Tao J
    Leukemia; 2009 Jan; 23(1):170-7. PubMed ID: 18843286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone marrow stromal cells prevent apoptosis of lymphoma cells by upregulation of anti-apoptotic proteins associated with activation of NF-kappaB (RelB/p52) in non-Hodgkin's lymphoma cells.
    Lwin T; Hazlehurst LA; Li Z; Dessureault S; Sotomayor E; Moscinski LC; Dalton WS; Tao J
    Leukemia; 2007 Jul; 21(7):1521-31. PubMed ID: 17476277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesenchymal stromal cells protect mantle cell lymphoma cells from spontaneous and drug-induced apoptosis through secretion of B-cell activating factor and activation of the canonical and non-canonical nuclear factor κB pathways.
    Medina DJ; Goodell L; Glod J; Gélinas C; Rabson AB; Strair RK
    Haematologica; 2012 Aug; 97(8):1255-63. PubMed ID: 22371181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-canonical NF-κB Plays a Pivotal Role in Non-Hodgkin's Lymphoma.
    Liu M; Song W; Zhang J; Sun M; Sun X; Yu Q
    Cell Biochem Biophys; 2015 Jul; 72(3):681-5. PubMed ID: 27352187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of B-cell-activating factor in adhesion and growth of human multiple myeloma cells in the bone marrow microenvironment.
    Tai YT; Li XF; Breitkreutz I; Song W; Neri P; Catley L; Podar K; Hideshima T; Chauhan D; Raje N; Schlossman R; Richardson P; Munshi NC; Anderson KC
    Cancer Res; 2006 Jul; 66(13):6675-82. PubMed ID: 16818641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of nuclear translocation of nuclear factor-kappaB despite lack of functional IkappaBalpha protein overcomes multiple defects in apoptosis signaling in human B-cell malignancies.
    Thomas RK; Sos ML; Zander T; Mani O; Popov A; Berenbrinker D; Smola-Hess S; Schultze JL; Wolf J
    Clin Cancer Res; 2005 Nov; 11(22):8186-94. PubMed ID: 16299251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD30-induced signaling is absent in Hodgkin's cells but present in anaplastic large cell lymphoma cells.
    Hirsch B; Hummel M; Bentink S; Fouladi F; Spang R; Zollinger R; Stein H; Dürkop H
    Am J Pathol; 2008 Feb; 172(2):510-20. PubMed ID: 18187570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone marrow stromal cells and the upregulation of interleukin-8 production in human T-cell acute lymphoblastic leukemia through the CXCL12/CXCR4 axis and the NF-kappaB and JNK/AP-1 pathways.
    Scupoli MT; Donadelli M; Cioffi F; Rossi M; Perbellini O; Malpeli G; Corbioli S; Vinante F; Krampera M; Palmieri M; Scarpa A; Ariola C; Foà R; Pizzolo G
    Haematologica; 2008 Apr; 93(4):524-32. PubMed ID: 18322253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heat stress triggers apoptosis by impairing NF-kappaB survival signaling in malignant B cells.
    Belardo G; Piva R; Santoro MG
    Leukemia; 2010 Jan; 24(1):187-96. PubMed ID: 19924145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rituximab (chimeric anti-CD20 monoclonal antibody) inhibits the constitutive nuclear factor-{kappa}B signaling pathway in non-Hodgkin's lymphoma B-cell lines: role in sensitization to chemotherapeutic drug-induced apoptosis.
    Jazirehi AR; Huerta-Yepez S; Cheng G; Bonavida B
    Cancer Res; 2005 Jan; 65(1):264-76. PubMed ID: 15665303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The serine/threonine kinase Pim-2 is a novel anti-apoptotic mediator in myeloma cells.
    Asano J; Nakano A; Oda A; Amou H; Hiasa M; Takeuchi K; Miki H; Nakamura S; Harada T; Fujii S; Kagawa K; Endo I; Yata K; Sakai A; Ozaki S; Matsumoto T; Abe M
    Leukemia; 2011 Jul; 25(7):1182-8. PubMed ID: 21475253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TRAF1 is involved in the classical NF-kappaB activation and CD30-induced alternative activity in Hodgkin's lymphoma cells.
    Guo F; Sun A; Wang W; He J; Hou J; Zhou P; Chen Z
    Mol Immunol; 2009 Aug; 46(13):2441-8. PubMed ID: 19540595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone marrow stroma-induced resistance of chronic lymphocytic leukemia cells to arsenic trioxide involves Mcl-1 upregulation and is overcome by inhibiting the PI3Kδ or PKCβ signaling pathways.
    Amigo-Jiménez I; Bailón E; Aguilera-Montilla N; Terol MJ; García-Marco JA; García-Pardo A
    Oncotarget; 2015 Dec; 6(42):44832-48. PubMed ID: 26540567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of BAFF/BAFF-R axis in B-cell non-Hodgkin lymphoma.
    Yang S; Li JY; Xu W
    Crit Rev Oncol Hematol; 2014 Aug; 91(2):113-22. PubMed ID: 24629840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone marrow stromal cells protect lymphoma B-cells from rituximab-induced apoptosis and targeting integrin α-4-β-1 (VLA-4) with natalizumab can overcome this resistance.
    Mraz M; Zent CS; Church AK; Jelinek DF; Wu X; Pospisilova S; Ansell SM; Novak AJ; Kay NE; Witzig TE; Nowakowski GS
    Br J Haematol; 2011 Oct; 155(1):53-64. PubMed ID: 21749361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diallyl trisulfide induces apoptosis by suppressing NF-κB signaling through destabilization of TRAF6 in primary effusion lymphoma.
    Shigemi Z; Furukawa Y; Hosokawa K; Minami S; Matsuhiro J; Nakata S; Watanabe T; Kagawa H; Nakagawa K; Takeda H; Fujimuro M
    Int J Oncol; 2016 Jan; 48(1):293-304. PubMed ID: 26647777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer-associated mesenchymal stroma fosters the stemness of osteosarcoma cells in response to intratumoral acidosis via NF-κB activation.
    Avnet S; Di Pompo G; Chano T; Errani C; Ibrahim-Hashim A; Gillies RJ; Donati DM; Baldini N
    Int J Cancer; 2017 Mar; 140(6):1331-1345. PubMed ID: 27888521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COX-2-independent effects of celecoxib sensitize lymphoma B cells to TRAIL-mediated apoptosis.
    Gallouet AS; Travert M; Bresson-Bepoldin L; Guilloton F; Pangault C; Caulet-Maugendre S; Lamy T; Tarte K; Guillaudeux T
    Clin Cancer Res; 2014 May; 20(10):2663-73. PubMed ID: 24637636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignant B-lymphoid cells with bone lesions express receptor activator of nuclear factor-kappaB ligand and vascular endothelial growth factor to enhance osteoclastogenesis.
    Shibata H; Abe M; Hiura K; Wilde J; Moriyama K; Sano T; Kitazoe K; Hashimoto T; Ozaki S; Wakatsuki S; Kido S; Inoue D; Matsumoto T
    Clin Cancer Res; 2005 Sep; 11(17):6109-15. PubMed ID: 16144909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.